Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients

Öncü, Mehmet; Akta, R.; Gizli, G.; Bilvanisi, S.; Yildiz, H.; Baran, A.

doi:10.26355/eurrev_202206_29084

Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients

Öncü M. R., Akta R. S., Gizli G., Bilvanisi S., Yildiz H., Baran A.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.26, sa.12, ss.4449-4455, 2022 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 12
Basım Tarihi: 2022
Doi Numarası: 10.26355/eurrev_202206_29084
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Sayfa Sayıları: ss.4449-4455
Anahtar Kelimeler: COVID-19, ABO blood groups, Comorbid diseases, Mortality
Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

OBJECTIVE: This study aimed to investigate the mortality relationship between COVID-19 and ABO blood groups and comorbid diseases. The aim of this study was to determine whether ABO blood groups and comorbid diseases can be used as a prognostic factor for hospitalization.